Close MyKPMG menu
Public debates on the Draft Government Resolution ”On adoption of calculation methodology for determining the manufacturer’s sale price limits for medical devices, the maximal whole-sale and retail mark-up on medical devices, included into the list of medical devices implanted into a human body under the state guarantees of free medical aid program” were started.
According to the document, certain medical devices of those implanted into a human body through free medical aid under the state guarantees will be regulated; activities of both sellers and buyers would be subject to regulation as well.
Introduction of the pricing control is supposed to solve the problem of market prices destabilization.
The Prime Minister Dmitry Medvedev signed the Government Resolution #6 dated January 05, 2015, that provides amendments to the Regulations for trade of certain products:
The adopted guidance is aimed to protect consumers purchasing medical devices in accordance with the Russian legislation.
The Federal Law #532-FZ “On Amendments to Certain Legislative Acts of the Russian Federation on Counteraction of Circulation of Counterfeit, Poor-Quality and Unregistered Pharmaceuticals, Medical Devices and Counterfeit Biologically Active Additives” came into force on January 23, 2015.
The Federal Law envisages:
- Amendments to Criminal Code of Russian Federation and Code of administrative offences of Russian Federation;
- Introduction of the following terms: “counterfeit biologically active additives”, “counterfeit medical device”, “poor-quality medical device”; a number of prohibitions for circulation of such devices is stipulated. The respective amendments were introduced to the Federal Law “On Quality and Safety of Food Products” and to the Federal Law “On Fundamentals of Public Healthсare Protection in Russia”.
The Russian Ministry of Healthcare informs on the preparation of a draft Government Resolution “On Amendments to the Government Resolution #865 dated October 29, 2010 “On State Price Regulation of Pharmaceuticals Included into Essential Drugs List”.
The proposed changes include:
The Resolution is aimed to reduce administrative obstacles in course of registration and re-registration of sales prices by Russian and foreign manufacturers, and also to optimize determining of the timeline and sequence of the applicable procedures.
The document should enter into force on May 01, 2015.
According to the Anti-Crisis Plan posted at the website of the Russian Government, by February 15 the Ministry for Industry and Trade will prepare a document introducing restrictions to importation of pharmaceuticals in case of two and more supply offers from Russian manufacturers, and restrictions to access of certain types of medical devices originating from foreign states to the state and municipal procurements.
Furthermore, the Ministry of Healthcare, the Federal Tariff Service and the Ministry of Economic Development are to prepare the documents providing for the possibility of one-off price indexation for EDL pharmaceuticals of lower and middle price segment.
The plan envisages the improvement of pharmaceuticals insurance for individuals, including those entitled for the state social aid, and also the reimbursement of losses caused by exchange rate differences when purchasing imported pharmaceuticals, including those purchased within government guarantees program of free medical aid for citizens.
Development of these regulations is aimed at implementation of the changes introduced by the Federal Law #429-FZ dated 22 December 2014 “On Amendments to the Federal Law “On Circulation of Pharmaceuticals”. The Orders will apply to all the participants engaged in pharmaceuticals circulation.
The Orders are expected to enter into force in the third quarter of 2015.
Selection standards for participation of Russia’s regions in the trial programs on improving pharmaceutical coverage for individuals in 2015-2016 have been developed. The purpose of the projects is detailed elaboration of organization and regulatory aspects of implementation of the reference price system, elaboration of free (or discounted) pharmaceutical coverage system for individuals at the expense of federal and regional budgets. The corresponding Decree #136-р was signed by the Prime Minister Dmitry Medvedev on January 30, 2015.
The following criteria have to be met by the regions for participation in the trial program:
According to the information posted on the website of the Cabinet of Ministers, the initiative is aimed at enhancement of the availability of high-quality, effective and safe pharmaceuticals based on the efficient and balanced system of pharmaceuticals coverage.
According to the Regulation, the main duties of the Coordination Council include:
The Minister of Healthcare is appointed as the Head of the Coordination Council which will include the representatives of federal executive bodies, regional state authorities, state academies of sciences, social and professional unions, governmental development institutions, credit institutions and healthcare businesses.
The previous Pharma Bulletin issues are accessible our site.
Prepared for you by KPMG in Russia and the CIS, Healthcare & Pharmaceuticals Sector.
© 2017 KPMG Audit LLC, the Mongolian member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity.